Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
McKinsey
Covington
Dow
Cipla
Medtronic
Chinese Patent Office
Citi

Generated: April 19, 2018

DrugPatentWatch Database Preview

TORECAN Drug Profile

« Back to Dashboard

When do Torecan patents expire, and when can generic versions of Torecan launch?

Torecan is a drug marketed by Novartis and is included in three NDAs.

The generic ingredient in TORECAN is thiethylperazine maleate. There is one drug master file entry for this compound. Additional details are available on the thiethylperazine maleate profile page.
Drug patent expirations by year for TORECAN
Synonyms for TORECAN
10H-Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-
10H-Phenothiazine, 2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]-
10H-Phenothiazine, 2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]-, (Z)-2-butenedioate (1:2)
1179-69-7
1179-69-7 (maleate (1:2))
118287-EP2275420A1
118287-EP2298764A1
118287-EP2298765A1
1420-55-9
2-(Ethylsulfanyl)-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine #
2-(ethylsulfanyl)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine
2-(Ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine
2-(ethylthio)-10-(3-(4-methylpiperazin-1-yl)propyl)-10H-phenothiazine
2-(Ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine
2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine;2-hydroxybutanedioic acid
2-(Ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]phenthiazine
2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine
2-(ethylthio)-10-[3-(4-methylpiperazino)propyl]phenothiazine;malic acid
2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;2-hydroxybutanedioic acid
2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;2-oxidanylbutanedioic acid
2-Ethylthio-10-(3-(4-methylpiperazin-1-yl)propyl)phenothiazine
3-Ethylmercapto-10-(1'-methylpiperazinyl-4'-propyl)phenothiazine
3B1-001257
52239-63-1 (malate (1:2))
8ETK1WAF6R
AB00514742
AC1L1KCZ
API0009132
BDBM78436
C07132
C22H29N3S2
CHEBI:9544
CHEMBL1378
cid_3085006
CTK6G4889
D02354
D0Y0ER
DB00372
DTXSID1023651
EINECS 215-819-0
ETHYLTHIOPERAZINE
GS-95
GS-95 (*Dimaleate*)
GTPL7306
HE066749
HSDB 3400
L000871
LS-105543
MLS002154140
Norzine
Norzine (*Dimaleate*)
Norzine (Salt/Mix)
NSC130044
Phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)-
Phenothiazine, 2-(ethylthio)-10-[3-(4-methyl-1-piperazinyl)propyl]-
PL045830
SCHEMBL49124
SMR001233447
Theithylperazine
Thiethylperazin
thiethylperazine
Thiethylperazine (USAN/INN)
Thiethylperazine [USAN:INN:BAN]
Thiethylperazine dimalate
Thiethylperazine dimaleate
Thiethylperazine malate
Thiethylperazine maleate
Thiethylperazine maleate (Salt/Mix)
Thiethylperazinum
Thiethylperazinum [INN-Latin]
Thiethylpipezazine
Thioethylperazine
Tietilperazina
Tietilperazina [DCIT]
Torecan (Salt/Mix)
Torecan (TN)
Tresten (Salt/Mix)
UNII-8ETK1WAF6R
XCTYLCDETUVOIP-UHFFFAOYSA-N
ZINC22446674

US Patents and Regulatory Information for TORECAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TORECAN thiethylperazine malate INJECTABLE;INJECTION 012754-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis TORECAN thiethylperazine maleate SUPPOSITORY;RECTAL 013247-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis TORECAN thiethylperazine maleate TABLET;ORAL 012753-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chinese Patent Office
Teva
Mallinckrodt
Healthtrust
Medtronic
Johnson and Johnson
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.